Intravenous injection of l-aspartic acid β-hydroxamate attenuates choroidal neovascularization via anti-VEGF and anti-inflammation. [electronic resource]
Producer: 20200217Description: 93-100 p. digitalISSN:- 1096-0007
- Angiogenesis Inhibitors -- administration & dosage
- Animals
- Antineoplastic Agents -- administration & dosage
- Asparagine -- administration & dosage
- Cells, Cultured
- Choroid -- pathology
- Choroidal Neovascularization -- drug therapy
- Disease Models, Animal
- Enzyme-Linked Immunosorbent Assay
- Inflammation -- drug therapy
- Injections, Intravenous
- Intravitreal Injections
- Mice
- Mice, Inbred C57BL
- Retinal Pigment Epithelium -- metabolism
- Vascular Endothelial Growth Factor A -- antagonists & inhibitors
- Visual Acuity
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.